THE COMPARATIVE ANALYSIS OF MORTALITY FROM MALIGNANT NEOPLASMS IN MOSCOW AND THE MOSCOW OBLAST

The City of Moscow and the Moscow Oblast form the Moscow agglomeration, but urban residents have advantages over rural ones. The contribution of deaths from malignant neoplasms (MNP) into mortality from all causes in higher in Moscow (23.3±0.5% and 18.3±2.8%) than in the Moscow Oblast (15.0±0.3% and 12.3±2.2%). The standardized mortality rate from MNP in Moscow made up to 146.82±2.05 per 100,000 of population in 2017–2019 and 131.35±8.92 in 2020–2022. In the Moscow Oblast the mentioned indicator made up to 138.54±0.12 and 131.84±4.10, respectively. In both City of Moscow and the Moscow Oblast 80% of deaths from all MNP in 2017–2019 and 2020–2022 were caused by 14 out of 33 groups with MNP and 13 of them coincided in both Subjects of the Russian Federation. The percentage of MNP of five localizations (trachea/bronchi/lungs, colorectal cancer, stomach, breast and pancreas) in Moscow made up to 50.6% and 51.7%, and in the Moscow Oblast up to 55.1% and 55.2% in both time periods accordingly. The COVID-19 pandemic resulted not in increasing of standardized mortality rate from MNP, but in decreasing of its percentage in the structure of total mortality. Despite differences between Moscow and the Moscow Oblast, the mortality from MNP in both Subjects of the Russian Federation differs insignificantly, and structure of causes of mortality from MNP is factually the same. The obtained data is an additional basis to confirm sufficient efficiency of the system of organization of medical care of patients with MNP in the studied Subjects of the Russian Federation.